0000876661-21-000027.txt : 20210107
0000876661-21-000027.hdr.sgml : 20210107
20210107165510
ACCESSION NUMBER: 0000876661-21-000027
CONFORMED SUBMISSION TYPE: 25-NSE/A
PUBLIC DOCUMENT COUNT: 2
FILED AS OF DATE: 20210107
DATE AS OF CHANGE: 20210107
EFFECTIVENESS DATE: 20210107
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: BRISTOL MYERS SQUIBB CO
CENTRAL INDEX KEY: 0000014272
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 220790350
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 25-NSE/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-01136
FILM NUMBER: 21514770
BUSINESS ADDRESS:
STREET 1: 430 E. 29TH STREET
STREET 2: 14 FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10016
BUSINESS PHONE: 2125464000
MAIL ADDRESS:
STREET 1: 430 E. 29TH STREET
STREET 2: 14 FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10016
FORMER COMPANY:
FORMER CONFORMED NAME: BRISTOL MYERS CO
DATE OF NAME CHANGE: 19891012
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: NEW YORK STOCK EXCHANGE LLC
CENTRAL INDEX KEY: 0000876661
IRS NUMBER: 000000000
STATE OF INCORPORATION: NY
FILING VALUES:
FORM TYPE: 25-NSE/A
BUSINESS ADDRESS:
STREET 1: 11 WALL STREET
CITY: NEW YORK
STATE: NY
ZIP: 10005
BUSINESS PHONE: 212-656-2060
MAIL ADDRESS:
STREET 1: 11 WALL STREET
CITY: NEW YORK
STATE: NY
ZIP: 10005
FORMER COMPANY:
FORMER CONFORMED NAME: NEW YORK STOCK EXCHANGE INC
DATE OF NAME CHANGE: 19910628
25-NSE/A
1
primary_doc.xml
X0203
0000876661
NEW YORK STOCK EXCHANGE LLC
0000014272
BRISTOL MYERS SQUIBB CO
001-01136
430 E 29 Street
New York
NY
NEW YORK
10016
(212) 546-4000
Bristol-Myers Squibb Contingent Value Rights
17 CFR 240.12d2-2(a)(4)
Lauren Frawley
Regulation Analyst
2021-01-07
EX-99.25
2
ruleprovisionnotice.htm
NOTIFICATION OF THE REMOVAL FROM LISTING AND REGISTRATION OF THE STATED SECURITIES
The New York Stock Exchange hereby notifies the SEC of its intention to remove the entire class of the stated securities from listing and registration on the Exchange at the opening of business on January 19, 2021, pursuant to the provisions of Rule 12d2-2 (a).
[ X ] 17 CFR 240.12d2-2(a)(4) All rights pertaining to the entire class of the security have been extinguished; provided, however, that where such an event occurs as a result of an order of a court or other governmental authority, the order shall be final, all applicable appeal periods shall have expired, and no appeals shall be pending.
The removal of the Bristol-Myers Squibb Contingent Value Rights of Bristol-Myers Squibb Company is being effected because the Exchange was reliably informed on January 1, 2021, that all rights pertaining to the entire class of this security were extinguished.
The Exchange also notifies the Securities and Exchange Commission that as a result of the above indicated conditions this security was suspended before market open on January 4, 2021.
Note: This Form 25 amends the previously filed Form 25 on January 4, 2020 under Accession Number 0000876661-21-000003.